166 related articles for article (PubMed ID: 6129506)
1. Clinical usefulness of monoclonal-antibody phenotyping in childhood acute lymphoblastic leukemia.
Kersey J; Goldman A; Abramson C; Nesbit M; Perry G; Gajl-Peczalska K; LeBien T
Lancet; 1982 Dec; 2(8313):1419-23. PubMed ID: 6129506
[TBL] [Abstract][Full Text] [Related]
2. Immunological subclassification of non-T, non-B acute lymphoblastic leukaemia in childhood.
Komada Y; Azuma E; Tanaka S; Ochiai H; Sakurai M
Scand J Haematol; 1986 Jan; 36(1):85-91. PubMed ID: 2937137
[TBL] [Abstract][Full Text] [Related]
3. Immunologic and clinicopathologic features of common acute lymphoblastic leukemia antigen-positive childhood T-cell leukemia. A Pediatric Oncology Group Study.
Dowell BL; Borowitz MJ; Boyett JM; Pullen DJ; Crist WM; Quddus FF; Russell EC; Falletta JM; Metzgar RS
Cancer; 1987 Jun; 59(12):2020-6. PubMed ID: 2952260
[TBL] [Abstract][Full Text] [Related]
4. [Distribution of leukemia-associated antigens (CALLA, P24 antigen and P20 antigen) on childhood acute lymphoblastic leukemia cells and nonhematopoietic tissues].
Ochiai J; Komada Y; Shimizu K; Kamiya H; Sakurai M
Rinsho Ketsueki; 1987 Sep; 28(9):1522-7. PubMed ID: 2963922
[No Abstract] [Full Text] [Related]
5. Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts.
Look AT; Melvin SL; Brown LK; Dockter ME; Roberson PK; Murphy SB
J Clin Invest; 1984 Jun; 73(6):1617-28. PubMed ID: 6233301
[TBL] [Abstract][Full Text] [Related]
6. Differential prognosis detected by immunophenotyping in acute lymphoblastic leukemia of childhood with poor prognostic factors.
Hirata R; Horibe K; Matsuoka H; Ueda R; Iwamura H
Jpn J Clin Oncol; 1987 Sep; 17(3):229-35. PubMed ID: 2959808
[TBL] [Abstract][Full Text] [Related]
7. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
Zipf TF; Fox RI; Dilley J; Levy R
Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
[TBL] [Abstract][Full Text] [Related]
8. Expression of HLA-DR alloantigens on acute lymphoblastic leukemia lymphoblasts.
Orgad S; Yunis EJ; Zaizov R; Ramot B; Altshuler R; Gazit E
Hum Immunol; 1984 Feb; 9(2):67-74. PubMed ID: 6421779
[TBL] [Abstract][Full Text] [Related]
9. [Acute nonmyeloid leukemia in adults. Study of membrane antigens and terminal transferase. Diagnostic and prognostic value].
Ifrah N; Perrot JY; Marie JP; Rio B; Julien C; Cadiou M; Boucheix C; Zittoun R
Presse Med; 1985 Jan; 14(3):137-41. PubMed ID: 3156336
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of non-T, non-B acute lymphocytic leukemia defined by the quantitative expression of Ia and common all antigens.
Okamura J; Letarte M; Gelfand EW
Leuk Res; 1984; 8(3):335-43. PubMed ID: 6235405
[TBL] [Abstract][Full Text] [Related]
11. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance.
Mirro J; Zipf TF; Pui CH; Kitchingman G; Williams D; Melvin S; Murphy SB; Stass S
Blood; 1985 Nov; 66(5):1115-23. PubMed ID: 3931724
[TBL] [Abstract][Full Text] [Related]
12. Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells.
Carrel S; De Tribolet N; Gross N
Eur J Immunol; 1982 Apr; 12(4):354-7. PubMed ID: 6954072
[TBL] [Abstract][Full Text] [Related]
13. Unfavorable presenting clinical and laboratory features are associated with CALLA-negative non-T, non-B lymphoblastic leukemia in children.
Pui CH; Williams DL; Raimondi SC; Melvin SL; Behm FG; Look AT; Dahl GV; Rivera GK; Kalwinsky DK; Mirro J
Leuk Res; 1986; 10(11):1287-92. PubMed ID: 2948078
[TBL] [Abstract][Full Text] [Related]
14. Multimarker analysis of childhood acute lymphoblastic leukemia (ALL): heterogeneity of cellular phenotypes and clinical relevance of immunological defined ALL subclasses.
Thoene I; Kabisch H
Haematol Blood Transfus; 1983; 28():126-30. PubMed ID: 6574949
[No Abstract] [Full Text] [Related]
15. Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement.
Ritz J; Sallan SE; Bast RC; Lipton JM; Clavell LA; Feeney M; Hercend T; Nathan DG; Schlossman SF
Lancet; 1982 Jul; 2(8289):60-3. PubMed ID: 6177990
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: a Pediatric Oncology Group Study.
Crist W; Pullen J; Boyett J; Falletta J; van Eys J; Borowitz M; Jackson J; Dowell B; Frankel L; Quddus F
Blood; 1986 Jan; 67(1):135-40. PubMed ID: 2934104
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in acute lymphoid leukaemia of childhood. II. Cell surface markers.
Révész T; Walcz E; Keleti J; Kardos G; Zimonyi I; Kovács I; Kajtár P; Schuler D
Acta Paediatr Hung; 1986; 27(4):295-301. PubMed ID: 2954566
[TBL] [Abstract][Full Text] [Related]
18. Differentiation antigens in acute leukaemia.
Reen DJ
Biochem Soc Trans; 1985 Apr; 13(2):420-2. PubMed ID: 3926556
[No Abstract] [Full Text] [Related]
19. Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA).
Hokland P; Rosenthal P; Griffin JD; Nadler LM; Daley J; Hokland M; Schlossman SF; Ritz J
J Exp Med; 1983 Jan; 157(1):114-29. PubMed ID: 6571733
[TBL] [Abstract][Full Text] [Related]
20. Utility of monoclonal antibodies in the immunologic phenotyping of acute lymphoblastic leukemia.
Yu AL; Royston I; Leung KL; Kung FH; Hartman GA; Lightsey AL; Vangrove J; Sobol RE
Hybridoma; 1982; 1(2):91-8. PubMed ID: 6985381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
